Jilin Aodong Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 4/6
Jilin Aodong Pharmaceutical Group has a total shareholder equity of CN¥29.3B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥32.9B and CN¥3.6B respectively.
Key information
7.3%
Debt to equity ratio
CN¥2.13b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥2.97b |
| Equity | CN¥29.26b |
| Total liabilities | CN¥3.64b |
| Total assets | CN¥32.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000623's short term assets (CN¥5.3B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 000623's short term assets (CN¥5.3B) exceed its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 000623 has more cash than its total debt.
Reducing Debt: 000623's debt to equity ratio has reduced from 9.3% to 7.3% over the past 5 years.
Debt Coverage: 000623's debt is not well covered by operating cash flow (14.4%).
Interest Coverage: Insufficient data to determine if 000623's interest payments on its debt are well covered by EBIT.